| 140118 | 140118 | Trial With Azacitidine in Newly Diagnosed Acute Myelogenous Leukemia (AML) Veterans Administration (VA) Elderly Patients Not Eligible for Standard Induction Therapy | Recruiting | No Results Available | Acute Myeloid Leukemia|Elderly | Drug: Azacitidine | https://ClinicalTrials.gov/show/NCT00728520 |
| 140119 | 140119 | Rifapentine Plus Moxifloxacin for Treatment of Pulmonary Tuberculosis | Active, not recruiting | No Results Available | Tuberculosis | Drug: Rifapentine, Moxifloxacin, Pyrazinamide, Isoniazid|Drug: Isoniazid, Rifampin, Pyrazinamide, Ethambutol | https://ClinicalTrials.gov/show/NCT00728507 |
| 140120 | 140120 | Compliance of HCV Genotype 1 Infected Patients Receiving PegIntron/Rebetol and a Patient Assistance Program (Study P04671) | Completed | Has Results | Hepatitis C, Chronic|Hepatitis C | Biological: PegIntron (peginterferon alfa-2b; SCH 54031)|Drug: Rebetol (ribavirin; SCH 18908)|Behavioral: Patient Assistance Program | https://ClinicalTrials.gov/show/NCT00728494 |
| 140121 | 140121 | The Role Of Gastroesophageal Reflux Disease (GERD) in Eosinophilic Esophagitis | Completed | Has Results | Eosinophilic Esophagitis|Gastroesophageal Reflux Disease|EE|GERD | Drug: Esomeprazole|Drug: Budesonide | https://ClinicalTrials.gov/show/NCT00728481 |
| 140122 | 140122 | A Study To Test The Impact Of PF- 00299804 On How The Body Handles Dextromethorphan In Cancer Patients | Completed | No Results Available | Advanced Malignant Solid Tumors | Drug: PF-00299804 | https://ClinicalTrials.gov/show/NCT00728468 |
| 140123 | 140123 | Examination of the Safety and Tolerability of NNC 0070-0002-0349 in Overweight/Obese Volunteers | Withdrawn | No Results Available | Metabolism and Nutrition Disorder|Obesity | Drug: NNC 0070-0002-0349|Drug: NNC 0070-0002-0349|Drug: NNC 0070-0002-0349|Drug: NNC 0070-0002-0349|Drug: NNC 0070-0002-0349|Drug: placebo|Drug: placebo|Drug: placebo|Drug: placebo|Drug: placebo | https://ClinicalTrials.gov/show/NCT00728455 |
| 140124 | 140124 | Impact of OncoDoc2 on Guideline Compliance in the Management of Breast Cancer | Completed | No Results Available | Breast Cancer | Device: ONCODOC LOGICIEL | https://ClinicalTrials.gov/show/NCT00728442 |
| 140125 | 140125 | Aerobic Exercise in Patients Receiving Chemotherapy for Cancer | Terminated | No Results Available | Cardiac Toxicity|Chemotherapeutic Agent Toxicity|Unspecified Adult Solid Tumor, Protocol Specific | Behavioral: exercise intervention | https://ClinicalTrials.gov/show/NCT00728429 |
| 140101 | 140101 | Brain Activity During Strategic Planning | Completed | No Results Available | Healthy Volunteers | | https://ClinicalTrials.gov/show/NCT00728741 |
| 140126 | 140126 | Study of Nasonex in the Relief of Nasal Congestion in Patients With Seasonal Allergic Rhinitis (Study P05583) | Completed | Has Results | Allergic Rhinitis | Drug: Mometasone furoate nasal spray (MFNS)|Drug: Matching placebo nasal spray | https://ClinicalTrials.gov/show/NCT00728416 |
| 140127 | 140127 | Metabolic and Therapeutic Effects of American and Korean Red Ginseng in the Treatment of Type 2 Diabetes | Active, not recruiting | No Results Available | Diabetes Mellitus Type 2 | Dietary Supplement: American Ginseng (Panax quinquefolius L.) and Korean Red Ginseng (steamed Panax C.A. Meyer)|Dietary Supplement: American Ginseng (Panax quinquefolius L.)|Dietary Supplement: Wheat Bran | https://ClinicalTrials.gov/show/NCT00728403 |
| 140102 | 140102 | Pregnenolone for Cognitive and Negative Symptoms in Schizophrenia | Active, not recruiting | No Results Available | Schizophrenia|Schizoaffective Disorder | Drug: Dietary Supplement: Pregnenolone|Dietary Supplement: Placebo | https://ClinicalTrials.gov/show/NCT00728728 |
| 140128 | 140128 | A Safety And Efficacy Study Of The Combination Of Oral PF-00299804 And Intravenous CP-751,871 Given Every 3 Weeks | Completed | No Results Available | Carcinoma, Non-Small Cell|Neoplasm Metastasis | Drug: PF-00299804 | https://ClinicalTrials.gov/show/NCT00728390 |
| 140129 | 140129 | An Exercise Intervention to Prevent Gestational Diabetes | Completed | No Results Available | Gestational Diabetes | Behavioral: Physical activity|Behavioral: Heath & Wellness | https://ClinicalTrials.gov/show/NCT00728377 |
| 140103 | 140103 | Efficacy of Budesonide-Formoterol in Bronchiectasis | Completed | No Results Available | Bronchiectasis | Drug: budesonide-formoterol single inhaler|Drug: High dose of budesonide|Drug: A|Drug: B | https://ClinicalTrials.gov/show/NCT00728715 |
| 140130 | 140130 | Anderson-Fabry Disease in Chronic Kidney Disease Patients Not on Renal Replacement Therapy | Completed | No Results Available | Focus of Study: Prevalence of Fabry Disease in CKD Population | | https://ClinicalTrials.gov/show/NCT00728364 |
| 140104 | 140104 | [Trial of device that is not approved or cleared by the U.S. FDA] | Withheld | No Results Available | | | https://ClinicalTrials.gov/show/NCT00728702 |
| 140105 | 140105 | Phase I Trial of an Investigational Small Pox Medication | Completed | Has Results | Orthopoxviral Disease|Smallpox|Monkey Pox | Drug: ST-246 Days 1 - 3|Drug: ST-246 Days 11 - 13 | https://ClinicalTrials.gov/show/NCT00728689 |
| 140106 | 140106 | Study to Evaluate the Effects of Kuvan on Individuals With Phenylketonuria (PKU) With Maladaptive Behaviors | Completed | No Results Available | Phenylketonuria | | https://ClinicalTrials.gov/show/NCT00728676 |
| 140107 | 140107 | Docetaxel and Cetuximab in Treating Patients With Metastatic Prostate Cancer | Completed | No Results Available | Prostate Cancer | Biological: cetuximab|Drug: docetaxel | https://ClinicalTrials.gov/show/NCT00728663 |
| 140108 | 140108 | A Retrospective Review of Malignant Liver Tumors | Completed | No Results Available | Liver Cancer | | https://ClinicalTrials.gov/show/NCT00728650 |
| 140109 | 140109 | Evaluating the Effectiveness of a Family Heart Health Educational Program (The FIT-Heart Study) | Completed | No Results Available | Cardiovascular Diseases|Heart Diseases | Behavioral: Family Passport to Heart Health Program|Behavioral: General Educational Materials | https://ClinicalTrials.gov/show/NCT00728637 |
| 140110 | 140110 | Assessing Prevalence Of Beta Lactamase Production From Clinical Isolates Of Hospitalized Patients And Comparison Of Antibiotic Susceptibility Patterns | Completed | No Results Available | Infection | | https://ClinicalTrials.gov/show/NCT00728624 |
| 140111 | 140111 | Preparation Rich in Growth Factors (PRGF) Treatment for Osteoarthritis of the Knee | Completed | No Results Available | Osteoarthritis of the Knee | Biological: PRGF|Drug: hyaluronic acid|Drug: placebo | https://ClinicalTrials.gov/show/NCT00728611 |
| 140112 | 140112 | Fractalkine, a CX3C Chemokine, Act as a Mediator of Ocular Angiogenesis | Completed | No Results Available | Proliferative Diabetic Retinopathy|Angiogenesis | | https://ClinicalTrials.gov/show/NCT00728598 |
| 140113 | 140113 | Palifermin in Preventing Oral Mucositis Caused by Chemotherapy and/or Radiation Therapy in Young Patients Undergoing Stem Cell Transplant | Withdrawn | No Results Available | Breast Cancer|Graft Versus Host Disease|Kidney Cancer|Leukemia|Lymphoma|Mucositis|Multiple Myeloma|Plasma Cell Neoplasm|Myelodysplastic Syndromes|Neuroblastoma|Ovarian Cancer|Sarcoma|Testicular Germ Cell Tumor | Biological: palifermin|Other: placebo | https://ClinicalTrials.gov/show/NCT00728585 |
| 140114 | 140114 | Logan Basic Technique Measured by Surface Electromyography (EMG) | Recruiting | No Results Available | Spinal Manipulation | Procedure: Logan Basic Technique and Surface EMG|Other: Surface EMG|Procedure: Logan Basic Technique Sham | https://ClinicalTrials.gov/show/NCT00728572 |
| 140115 | 140115 | Evaluation of Local Anlagesia Into the Trocar Site During Operative Laparosocpy | Not yet recruiting | No Results Available | Pain | Drug: bupivacain 0.5% | https://ClinicalTrials.gov/show/NCT00728559 |
| 140116 | 140116 | NAT2 in Re-challenge of INH in Patients With Hepatitis | Recruiting | No Results Available | Tuberculosis|Hepatotoxicity | Drug: Isoniazid (Rifinah) | https://ClinicalTrials.gov/show/NCT00728546 |
| 140117 | 140117 | Open-Label, Randomised Parallel-Group Study | Withdrawn | No Results Available | Prostate Cancer | Drug: Degarelix|Drug: Degarelix | https://ClinicalTrials.gov/show/NCT00728533 |